Division of Cellular and Gene Therapies Center for Biologics Evaluation and Research (CBER) Food and Drug Administration, Silver Spring, Maryland

A postdoctoral position is available to perform research on genome editing technologies, with a focus on specificity and efficiency of CRISPR-based RNA editing. CRISPR systems have great potential in developing potent gene and cell therapies, but a comprehensive understanding of their specificity is needed in order to ensure patient safety. The research fellow will use molecular and cellular tools to understand impact of genome editing tools on genomic and transcriptomic integrity of human cells including stem cells. The laboratory is in the state-of-the-art interdisciplinary research facility at FDA’s Center for Biologics Evaluation and Research (CBER), Silver Spring, Maryland. Candidates will be offered a competitive salary depending on their experience..

The ideal candidate would be a highly motivated individual with a Ph.D. degree and a demonstrated record or potential of scientific productivity. Candidates with research experience in molecular biology, cell biology or immunology will receive the strongest consideration. Expertise in common molecular and cell biology techniques such as molecular cloning and quantitative PCRs is essential. Experience with flow cytometry and next-gen sequencing is desirable. 

Please email your CV, a brief cover letter outlining research interests, research experience, and future career goals, and the names of three references to:

Zhaohui Ye, Ph.D.
Email: zhaohui.ye@fda.hhs.gov

Posted Until Deadline: September 30, 2022

The NIH is dedicated to building a diverse community in its training and employment programs.